22nd Valve Disease, Structural Interventions and Diastology Summit – Cleveland Clinic 2020 - Medical Videos | Board Review Courses

22nd Valve Disease, Structural Interventions and Diastology Summit – Cleveland Clinic 2020

Regular price
$40.00
Sale price
$40.00
Regular price
Sold out
Unit price
per 

YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT

22nd Valve Disease, Structural Interventions and Diastology Summit – Cleveland Clinic 2020

Topics And Speakers:

Session 1: Valve Disease– Focus on the Mitral Valve

Complexities of the Mitral Valve: Structure and Mechanics Robert J. Siegel, MD
Mitral Regurgitation: Etiology and Quantification Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC
Management of Mitral Regurgitation L. Leonardo Rodriguez, MD
Primary and Secondary Mitral Regurgitation: Who, Who-Not, and When to Do Surgery? Gosta Pettersson, MD, PhD
Percutaneous Mitral Valve Repair: Imaging and Procedural Guidance Robert J. Siegel, MD
How Does the Sonographer Acquire Quality Data for the Mitral Valve and the Left Atrium? Amy Dillenbeck, MS, ACS, RDCS, FASE
Panel Discussion

Session 2: Structural Interventions– Mitral Valve and Left Atrium

Exercise Testing in Mitral Valve Disease: What Do the Guidelines Say? Christine Jellis, MD, PhD
Evaluation of Valvular Regurgitation After Percutaneous Valve Repair: What Do the New Guidelines Say? Robert J. Siegel, MD
LAA Occluder Devices – Current Indications Robert J. Cubeddu, MD
Calcific Mitral Stenosis: Percutaneous and Surgical Options and Challenges Samir Kapadia, MD
Panel Discussion

Session 3: Controversies in Mitral Valve Disease

Debate: Transcatheter Mitral Leaflet Repair Will Be Routinely Used to Treat Severe Functional Mitral Regurgitation Robert J. Siegel, MD
Debate: Transcatheter Mitral Leaflet Repair Will Not Be Routinely Used to Treat Severe Functional Mitral Regurgitation Samir Kapadia, MD
Debate: Transcatheter Mitral Leaflet Repair Pro Rebuttal Robert J. Siegel, MD
Transcatheter Mitral Leaflet Repair Debate Discussion

Session 4: Percutaneous Mitral Valve Intervention Cases

Percutaneous Mitral Valve Case #1 Robert J. Siegel, MD
Double Trouble: A Case of Mitral Valve Disease With Two Mechanisms Balint Laczay, MD
Percutaneous Mitral Valve Case #3 Michael Chetrit, MD
Mitraclip: The Corner Pocket Robert J. Cubeddu, MD
Mechanisms Mechanical Valve Failure Gosta Pettersson, MD, PhD

Session 5: Valve Disease– Focus on the Aortic Valve

Low Flow, Low Gradient Aortic Stenosis: What Does This Mean and How to Image? Rebecca Hahn, MD
Stress Echo in Aortic Stenosis: Indications, Methods, Impact on Management Christine Jellis, MD, PhD
Aortic Root Anatomy: Utilizing the Best of Echo and CT Imaging to Optimize TAVR Outcomes L. Leonardo Rodriguez, MD
TAVR vs. SAVR: New Devices and Expanding Indications Samir Kapadia, MD
Panel Discussion

Session 6: Structural Interventions and the Tricuspid Valve

The Forgotten Valve: Tricuspid Valve Therapies Jose Navia, MD
Imaging the Tricuspid Valve for Procedural Guidance Rebecca Hahn, MD
Percutaneous Treatment of Tricuspid Regurgitation: Which Patients and What Devices? Samir Kapadia, MD
How Does the Sonographer Acquire Quality Data for the Tricuspid Valve and Right- Sided Chambers? Anne Campbell, MS, RDCS
Panel Discussion

Session 7: Controversies in Aortic Valve Disease

Debate: TAVR Will Replace SAVR in Low and Moderate Risk Aortic Stenosis Patients – Pro Rebecca Hahn, MD
Debate: TAVR Will Replace SAVR in Low and Moderate Risk Aortic Stenosis Patients – Con Gosta Pettersson, MD, PhD
Debate: TAVR Will Replace SAVR in Low and Moderate Risk Aortic Stenosis Patients – Pro Rebecca Hahn, MD
Debate: TAVR Will Replace SAVR in Low and Moderate Risk Aortic Stenosis Patients – Con Gosta Pettersson, MD, PhD
Panel Discussion

Session 8: Aortic Valve Intervention Cases

Aortic Valve Interventions Case #1 Robert J. Siegel, MD
Severe Tricuspid Regurgitation Rebecca Hahn, MD
Mitral Balloon Valvuloplasty in Severe Calcific Mitral Stenosis Robert J. Cubeddu, MD
Aortic Valve Interventions Case #4 Gosta Pettersson, MD, PhD

Session 9: Diastolic Function Evaluation

Physiology of Left Ventricular Diastolic Function: Is it Really That Complicated? Sherif Nagueh, MD
Estimating LV Filling Pressures With Doppler Echo and Hemodynamics Partho Sengupta, MD
How to Handle Indeterminate and Difficult Cases Amy Dillenbeck, MS, ACS, RDCS, FASE
Diastology Guidelines: State of the Art Sherif Nagueh, MD
Cardiac Amylodosis: What is New in 2020? Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC
Panel Discussion

Session 10: Myocardial and Pericardial Diseases

How to Differentiate Athlete’s Heart From Non-obstructive Hypertrophic Cardiomyopathy – Management Pearls Craig Asher, MD
Radiation Associated Cardiac Disease: The Role of Multimodality Imaging Christine Jellis, MD, PhD
Complicated Pericarditis: A Paradigm Shift of Treatment Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC
Artificial Intelligence: Is This Going to Help the Clinician? Partho Sengupta, MD
Contrast Echo for the Assessment of Cardiac Structure and Function Amy Dillenbeck, MS, ACS, RDCS, FASE

Session 11: Controversies in Cardiac Imaging

Debate: Strain Will Replace EF in Evaluation of Heart Disease Partho Sengupta, MD
Debate: Strain Will Not Replace EF in Evaluation of Heart Disease Sherif Nagueh, MD
Strain Debate: Pro Rebuttal Partho Sengupta, MD
Strain Debate: Con Rebuttal Sherif Nagueh, MD
Strain Debate Discussion

Session 12: Cases in Constriction, Restriction, Contrast and More

Case #1 Michael Chetrit, MD
Case #2 Sherif Nagueh, MD
Case #3: Unrepaired Tetrology of Fallot in an Adult Jared Klein, MD, MPH
Case #4: Worsening TRA After Pericadiectomy Ray Tabucanon, MD

Release Date: 5/15/20
CME Expiration: 5/14/22